We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

82 hedge funds and large institutions have $261M invested in Minerva Neurosciences in 2017 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 39 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

336% more call options, than puts

Call options by funds: $941K | Put options by funds: $216K

160% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 15

122% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 9

27% more capital invested

Capital invested by funds: $205M → $261M (+$55.4M)

15% more funds holding

Funds holding: 71 → 82 (+11)

1.05% more ownership

Funds ownership: 8.98% → 10.03% (+1%)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
82
Holders Change
+11
Holders Change %
+15.49%
% of All Funds
2.04%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
20
Increased
39
Reduced
15
Closed
9
Calls
$941K
Puts
$216K
Net Calls
+$725K
Net Calls Change
+$642K

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$10.5M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$9.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.5M
4
SFM
Sphera Funds Management
Israel
+$3.83M
5
JGC
J. Goldman & Co
New York
+$3.41M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$6.57M
2
HCMT
Highland Capital Management (Texas)
Texas
-$5.34M
3
O
OrbiMed
New York
-$2.91M
4
CAM
Cormorant Asset Management
Massachusetts
-$2.51M
5
NC
Nexthera Capital
New York
-$1.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$805K +$86.8K +1,341 +13%
TCIM
27
TIAA CREF Investment Management
New York
$746K +$280K +4,322 +70%
TD Asset Management
28
TD Asset Management
Ontario, Canada
$537K +$272K +4,199 +124%
GCP
29
GSA Capital Partners
United Kingdom
$519K +$154K +2,375 +48%
Millennium Management
30
Millennium Management
New York
$517K -$140K -2,162 -23%
PRCM
31
Pine River Capital Management
Minnesota
$443K +$405K +6,250 New
AllianceBernstein
32
AllianceBernstein
Tennessee
$408K -$81.7K -1,262 -18%
TA
33
Teachers Advisors
New York
$404K +$117K +1,808 +46%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$398K +$152K +2,349 +72%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$394K +$25K +387 +7%
SCM
36
Sterling Capital Management
North Carolina
$369K +$214K +3,311 +175%
Swiss National Bank
37
Swiss National Bank
Switzerland
$354K – – –
Citadel Advisors
38
Citadel Advisors
Florida
$354K +$214K +3,309 +196%
LCM
39
Laurion Capital Management
New York
$326K +$298K +4,600 New
Goldman Sachs
40
Goldman Sachs
New York
$311K -$22.7K -351 -7%
Charles Schwab
41
Charles Schwab
California
$307K – – –
AQR Capital Management
42
AQR Capital Management
Connecticut
$305K – – –
VKH
43
Virtu KCG Holdings
New York
$297K +$271K +4,192 New
AA
44
ALPS Advisors
Colorado
$293K +$25.8K +398 +11%
Deutsche Bank
45
Deutsche Bank
Germany
$280K +$65.4K +1,011 +34%
VEA
46
Virtus ETF Advisers
New York
$275K +$82.9K +1,281 +49%
Tudor Investment Corp
47
Tudor Investment Corp
Connecticut
$266K +$243K +3,750 New
Jacobs Levy Equity Management
48
Jacobs Levy Equity Management
New Jersey
$252K – – –
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$249K +$87.4K +1,350 +62%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$240K +$57.8K +893 +36%
1
2
3 4

NERV Hedge Fund Activity: Q2 2017 in Review

82 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q2 2017, worth a combined $261M — up 27% from $205M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new NERV positions and 9 closed out — a net gain of 11 holders — while 39 added to existing stakes and 15 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $10.5M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $6.57M sold.

  • 82 institutional investors held Minerva Neurosciences (NERV) as of Q2 2017, up from 71 in Q1 2017.
  • Funds reported $261M of Minerva Neurosciences stock for Q2 2017, up 27% quarter-over-quarter.
  • 20 funds opened new Minerva Neurosciences positions in Q2 2017 and 9 closed out, a net change of +11 holders.
  • The largest Minerva Neurosciences buyer in Q2 2017 was T. Rowe Price Associates, an estimated $10.5M added.
  • The largest Minerva Neurosciences seller in Q2 2017 was Perceptive Advisors, an estimated $6.57M sold.

Based on aggregated 13F filings for Q2 2017.